Literature DB >> 1282218

Stimulation of ACTH/cortisol by intravenously infused substance P in normal men: inhibition by sodium valproate.

V Coiro1, L Capretti, R Volpi, C Davoli, A Marcato, U Cavazzini, G Caffarri, G Rossi, P Chiodera.   

Abstract

The effect of synthetic substance P (SP), infused intravenously in doses of 0.5, 1 or 1.5 pmol/kg-1/min-1 over 60 min on ACTH/cortisol secretion was evaluated in 7 healthy men. SP tests and a control test with normal saline were randomly performed at weekly intervals. During tests, SP infusion did not produce untoward side effects or changes in blood pressure. Plasma ACTH and cortisol levels were not modified when normal saline or the lowest dose of SP were infused, whereas they were significantly increased in a dose-dependent fashion when higher amounts of SP were administered. Further studies were performed in another 7 healthy men to test the possible influence of GABAergic neurotransmission on the ACTH/cortisol response to SP. For this purpose, subjects were tested with SP (1.5 pmol/kg-1/min-1) alone and on a different occasion with SP after pretreatment with the GABAergic agent sodium valproate (200 mg 16, 8 and 1 h before the SP test). Again, the administration of SP induced a significant increase in plasma ACTH and cortisol levels. The pretreatment with sodium valproate completely abolished both ACTH and cortisol responses to SP. These data demonstrate for the first time in humans that the systemic infusion of SP stimulates ACTH/cortisol secretion, suggesting the involvement of a GABAergic mechanism in the regulation of the action of SP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282218     DOI: 10.1159/000126262

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man.

Authors:  D E Newby; D G Sciberras; C J Ferro; B J Gertz; D Sommerville; A Majumdar; R C Lowry; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

4.  Visualization of the thymus by substance P receptor scintigraphy in man.

Authors:  P M van Hagen; W A Breeman; J C Reubi; P T Postema; P J van den Anker-Lugtenburg; D J Kwekkeboom; J Laissue; B Waser; S W Lamberts; T J Visser; E P Krenning
Journal:  Eur J Nucl Med       Date:  1996-11

5.  The neuropeptide substance P regulates aldosterone secretion in human adrenals.

Authors:  Julien Wils; Céline Duparc; Estelle Louiset; Hervé Lefebvre; Anne-Françoise Cailleux; Antoine-Guy Lopez; Caroline Guiheneuf; Isabelle Boutelet; Hadrien-Gaël Boyer; Christophe Dubessy; Saloua Cherifi; Bruno Cauliez; Françoise Gobet; Guillaume Defortescu; Jean-François Ménard
Journal:  Nat Commun       Date:  2020-05-29       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.